Annual EBIT
-$71.60 M
-$39.76 M-124.89%
31 March 2022
Summary:
Sio Gene Therapies annual earnings before interest & taxes is currently -$71.60 million, with the most recent change of -$39.76 million (-124.89%) on 31 March 2022. During the last 3 years, it has fallen by -$39.76 million (-124.89%).SIOX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$4.48 M
-$1.21 M-36.80%
31 December 2022
Summary:
Sio Gene Therapies quarterly earnings before interest & taxes is currently -$4.48 million, with the most recent change of -$1.21 million (-36.80%) on 31 December 2022.SIOX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$29.41 M
+$20.89 M+41.53%
31 December 2022
Summary:
Sio Gene Therapies TTM earnings before interest & taxes is currently -$29.41 million, with the most recent change of +$20.89 million (+41.53%) on 31 December 2022.SIOX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -124.9% | +82.3% | +52.4% |
| 5 y5 years | +41.0% | +65.5% | +50.4% |
SIOX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +143.8% | +38.4% | +18.2% |
Sio Gene Therapies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | -$4.48 M(+36.8%) | -$29.41 M(-41.5%) |
| Sept 2022 | - | -$3.28 M(-61.6%) | -$50.30 M(-26.3%) |
| June 2022 | - | -$8.53 M(-34.9%) | -$68.22 M(-4.7%) |
| Mar 2022 | -$71.60 M(+124.9%) | -$13.12 M(-48.3%) | -$71.60 M(+16.0%) |
| Dec 2021 | - | -$25.37 M(+19.7%) | -$61.72 M(+31.2%) |
| Sept 2021 | - | -$21.20 M(+77.9%) | -$47.05 M(+30.8%) |
| June 2021 | - | -$11.92 M(+268.0%) | -$35.99 M(+13.0%) |
| Mar 2021 | -$31.84 M(-53.1%) | -$3.24 M(-69.7%) | -$31.84 M(-28.5%) |
| Dec 2020 | - | -$10.70 M(+5.7%) | -$44.53 M(-4.9%) |
| Sept 2020 | - | -$10.13 M(+30.4%) | -$46.80 M(-4.7%) |
| June 2020 | - | -$7.77 M(-51.2%) | -$49.12 M(-27.6%) |
| Mar 2020 | -$67.81 M(-44.1%) | -$15.93 M(+22.7%) | -$67.81 M(+14.4%) |
| Dec 2019 | - | -$12.98 M(+4.3%) | -$59.30 M(-24.6%) |
| Sept 2019 | - | -$12.44 M(-53.0%) | -$78.66 M(-19.8%) |
| June 2019 | - | -$26.46 M(+256.9%) | -$98.02 M(-19.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | -$121.40 M(-43.0%) | -$7.42 M(-77.1%) | -$121.40 M(-11.7%) |
| Dec 2018 | - | -$32.34 M(+1.7%) | -$137.50 M(-14.6%) |
| Sept 2018 | - | -$31.81 M(-36.2%) | -$161.09 M(-18.7%) |
| June 2018 | - | -$49.84 M(+112.0%) | -$198.07 M(-7.1%) |
| Mar 2018 | -$213.11 M(+17.8%) | -$23.51 M(-58.0%) | -$213.11 M(-12.3%) |
| Dec 2017 | - | -$55.93 M(-18.7%) | -$243.06 M(+3.4%) |
| Sept 2017 | - | -$68.80 M(+6.1%) | -$235.11 M(+13.1%) |
| June 2017 | - | -$64.87 M(+21.3%) | -$207.83 M(+14.9%) |
| Mar 2017 | -$180.87 M(+35.8%) | -$53.47 M(+11.5%) | -$180.87 M(+14.5%) |
| Dec 2016 | - | -$47.97 M(+15.5%) | -$157.99 M(-8.4%) |
| Sept 2016 | - | -$41.52 M(+9.5%) | -$172.57 M(+18.0%) |
| June 2016 | - | -$37.91 M(+23.9%) | -$146.19 M(+9.8%) |
| Mar 2016 | -$133.16 M | -$30.59 M(-51.1%) | -$133.16 M(+29.8%) |
| Dec 2015 | - | -$62.55 M(+313.1%) | -$102.58 M(+156.3%) |
| Sept 2015 | - | -$15.14 M(-39.1%) | -$40.02 M(+60.9%) |
| June 2015 | - | -$24.88 M | -$24.88 M |
FAQ
- What is Sio Gene Therapies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sio Gene Therapies?
- What is Sio Gene Therapies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sio Gene Therapies?
What is Sio Gene Therapies annual earnings before interest & taxes?
The current annual EBIT of SIOX is -$71.60 M
What is the all time high annual EBIT for Sio Gene Therapies?
Sio Gene Therapies all-time high annual earnings before interest & taxes is -$29.37 M
What is Sio Gene Therapies quarterly earnings before interest & taxes?
The current quarterly EBIT of SIOX is -$4.48 M
What is the all time high quarterly EBIT for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly earnings before interest & taxes is -$3.24 M
What is Sio Gene Therapies TTM earnings before interest & taxes?
The current TTM EBIT of SIOX is -$29.41 M
What is the all time high TTM EBIT for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM earnings before interest & taxes is -$24.88 M